US Antibiotics: A U.S. Led Strategic Focus with Global Market Influence Repositioning a Core U.S. Asset as a Strategic Opportunity
The U.S. antibiotics market is frequently characterized as economically unattractive due to pricing pressure, stewardship constraints, antimicrobial resistance (AMR), and manufacturing complexity. From U.S. Pharma Consulting’s perspective, this conclusion reflects a misinterpretation of the problem rather than a lack of opportunity.
Please fill out the form to download the Case Study or Slide Deck
